Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Decade in review—movement disorders

Tracking the pathogenesis of movement disorders

Nature Reviews Neurology volume 11, pages 618–619 (2015)Cite this article

Subjects

Since 2005, we have made substantial progress in understanding the pathophysiology and natural history of movement disorders such as Parkinson disease and Huntington disease. However, disease-modifying therapies for these conditions have proved elusive and, as a consequence, treatments remain largely symptomatic.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Suchowersky, O. et al. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review). Neurology 66, 968–975 (2006).

    Article  CAS  Google Scholar 

  2. Tolosa, E., Gaig, C., Santamaria, J. & Compta, Y. Diagnosis and the premotor phase of Parkinson disease. Neurology 72 (Suppl. 2), S12–S20 (2009).

    Article  Google Scholar 

  3. Barone, P. et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov. Disord. 24, 1641–1649 (2009).

    Article  Google Scholar 

  4. den Brok, M. G. et al. Apathy in Parkinson's disease: a systematic review and meta-analysis. Mov. Disord. 30, 759–769 (2015).

    Article  Google Scholar 

  5. Van der Brug, M. P., Singleton, A, Gasser, T. & Lewis, P. A. Parkinson's disease: from human genetics to clinical trials. Sci. Transl. Med. 7, 305ps20 (2015).

    Article  Google Scholar 

  6. Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA 313, 584–593 (2015).

  7. Tabrizi, S. J. et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 12, 637–649 (2013).

    Article  Google Scholar 

  8. Stanek, L. M. et al. Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease. Hum. Gene Ther. 25, 461–474 (2014).

    Article  CAS  Google Scholar 

  9. Leen, W. G. et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133, 655–670 (2010).

    Article  Google Scholar 

  10. Bigi, S., Hldio, M., Twilt, M., Dalmau, J. & Benseler, S. M. The growing spectrum of antibody-associated inflammatory brain diseases in children. Neurol. Neuroimmunol. Neuroinflamm. 2, e92 (2015).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Alberta, 7-112Q Clinical Sciences Building, 11350—83 Avenue, Edmonton, T6G 2G3, AB, Canada

    Oksana Suchowersky

Authors
  1. Oksana Suchowersky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oksana Suchowersky.

Ethics declarations

Competing interests

The author has received research grants from AbbVie and Biotie. She has received honoraria from AbbVie, Allergan and Merz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suchowersky, O. Tracking the pathogenesis of movement disorders. Nat Rev Neurol 11, 618–619 (2015). https://doi.org/10.1038/nrneurol.2015.201

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2015.201

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing